The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer.
暂无分享,去创建一个
Masahiro Tsuboi | Jitsuo Usuda | Harubumi Kato | Tatsuo Ohira | Naohiro Kajiwara | J. Usuda | H. Kato | T. Ohira | M. Tsuboi | H. Saji | N. Kajiwara | O. Uchida | K. Miyajima | Kuniharu Miyajima | Hisashi Saji | Osamu Uchida
[1] Julio Astudillo,et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. , 2006, The Lancet. Oncology.
[2] H. Wada,et al. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] G. Giaccone,et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. , 2003, Journal of the National Cancer Institute.
[4] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[5] R. Schilsky,et al. Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] I Wauters,et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer , 2009 .
[7] L. Seymour,et al. A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR.10. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Bengt Bergman,et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. , 2004, The New England journal of medicine.
[9] Gefitinib in the adjuvant setting: safety results from a phase III study in patients with completely resected non-small cell lung cancer , 2005, Anti-cancer drugs.
[10] L. Seymour,et al. A prospective randomised trial of adjuvant vinorelbine (VIN) and cisplatin (CIS) in completely resected stage 1B and II non small cell lung cancer (NSCLC) Intergroup JBR.10 , 2004 .
[11] K. Matsuo,et al. Role of Adjuvant Chemotherapy in Patients With Resected Non-Small-Cell Lung Cancer: Reappraisal With a Meta-analysis of Randomized Controlled Trials , 2006 .
[12] T. Treasure,et al. Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis. , 2004, The Journal of thoracic and cardiovascular surgery.
[13] Emmanuelle Comets,et al. Comparison of the Pharmacokinetics of S-1, an Oral Anticancer Agent, in Western and Japanese Patients , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[14] O. Brodin,et al. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials , 1995 .
[15] M. Parmar,et al. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[16] G. Scagliotti,et al. Lung Adjuvant Cisplatin Evaluation (LACE): A pooled analysis of five randomized clinical trials including 4,584 patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] H. Kato,et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. , 2004, The New England journal of medicine.
[18] R. Pazdur,et al. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[19] E. Miyaoka,et al. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. , 2005, Lung cancer.